Combating giardiasis by investigating new potent compound series as leads for improved treatment options

贾第鞭毛虫寄生虫感染了全球约10亿人，并造成了严重的发病率和劣势。没有获得许可的疫苗，目前的治疗方案不足，导致依从性差、治疗失败、快速再感染和耐药性。需要新的疗法来对抗这种寄生虫，并改善全世界数百万人的健康。我们将通过研究治疗贾第鞭毛虫感染的新候选药物来解决这个问题。

Giardia parasites infect ~1 billion people globally and are responsible for significant morbidity and disadvantage. There is no licensed vaccine and current treatment options are inadequate, resulting in poor compliance, treatment failures, rapid re-infection and drug resistance. New therapies are needed to combat this parasite and improve the health of millions world-wide. We will address this issue by investigating new drug candidates for the treatment of Giardia infections.